This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Approval of large-language models by Chinese regulator set to spur generative AI development

By MLex Staff ( September 4, 2023, 10:12 GMT | Insight) -- The approval in China of 11 large-language models for public rollout is set to spur the development of generative artificial intelligence in the country amid intense global competition in the sector. China’s Cyberspace Administration recently disclosed that the large-language models were among about 110 registered algorithms for deep-synthesis services that include those involved in text generation, image generation, video synthesis, audio synthesis, digital human synthesis and virtual scene generation. The registration and the security assessments of the large-language models clears the way for their public debut. The approval in China of 11 large-language models for public rollout is set to spur the development of generative artificial intelligence in the country amid intense global competition in the sector....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections